Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Managing specific symptoms in people with multiple sclerosis.

T Henze1

  • 1Klinik am Regenbogen, Fachklinik für Neurologische Rehabilitation, Eichendorffstr. 21, D-93149 Nittenau, Germany. t.henze@klinikamregenbogen.de

International MS Journal
|January 19, 2006
PubMed
Summary

Symptomatic treatment is crucial for managing multiple sclerosis (MS) symptoms like spasticity, fatigue, pain, and bladder dysfunction. This review outlines consensus-based therapeutic strategies to improve quality of life for MS patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[What is new in symptomatic MS treatment: Part 3-bladder dysfunction].

Der Nervenarzt·2017
Same author

[New aspects of symptomatic MS treatment: Part 4-sexual dysfunction and eye movement disorders].

Der Nervenarzt·2017
Same author

[New aspects of symptomatic MS treatment: Part 6 - cognitive dysfunction and rehabilitation].

Der Nervenarzt·2017
Same author

[New aspects of symptomatic MS treatment: Part 5 - fatigue].

Der Nervenarzt·2017
Same author

[What is new in symptomatic MS treatment: Part 2-gait disorder and spasticity].

Der Nervenarzt·2017
Same author

[What is new in symptomatic MS treatment: Part 1-introduction and methodical approach, ataxia and tremor].

Der Nervenarzt·2017

Area of Science:

  • Neurology
  • Clinical Therapeutics
  • Multiple Sclerosis Management

Background:

  • Symptomatic treatment is a key component of multiple sclerosis (MS) therapy, alongside immunomodulation and immunosuppression.
  • Effective management of MS symptoms is vital for improving functional ability and quality of life, and preventing secondary complications.
  • A need exists for clear, consensus-driven therapeutic strategies for various MS-related symptoms.

Purpose of the Study:

  • To review established recommendations for the symptomatic treatment of multiple sclerosis.
  • To focus on key symptoms including spasticity, fatigue, pain, and neurogenic bladder dysfunction.
  • To present strategies developed by the Multiple Sclerosis Treatment Consensus Group of the German MS Society.

Main Methods:

Related Experiment Videos

  • Review of treatment recommendations.
  • Consensus development by a specialized group.
  • Focus on specific MS-related symptoms.

    • Main Results:

    • The paper details consensus-based recommendations for managing MS-related spasticity.
    • Strategies for treating MS-related fatigue are presented.
    • Recommendations for addressing MS-related pain and neurogenic bladder dysfunction are reviewed.

    Conclusions:

    • Consensus-driven therapeutic strategies are essential for effective symptomatic treatment in MS.
    • The reviewed recommendations provide a framework for clinicians managing common MS symptoms.
    • Adherence to these guidelines can help improve patient outcomes and quality of life in multiple sclerosis.